Skip to main content

All BHMG Oncology

Submissions from 2020 2020

A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients, Murugesan Manoharan

A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer, Murugesan Manoharan

Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup, Starr Mautner

Reconstructive Surgery and Postoperative Care for Breast Cancer, Miguel Medina and Harry Salinas

Palliative Care and Symptom Management in Breast and Gynecological Cancers, Suleyki Medina

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL, Minesh Mehta

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma, Minesh Mehta

Effectiveness of Radiofrequency Ablation in the Treatment of Painful Osseous Metastases: A Correlation Meta-Analysis with Machine Learning Cluster Identification, Minesh Mehta

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions, Minesh Mehta

High-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539, Minesh Mehta

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001, Minesh Mehta

Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure, Minesh Mehta

Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?, Minesh Mehta

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma, Minesh Mehta

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients, Minesh Mehta

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424, Minesh Mehta

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02, Minesh Mehta

Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424, Minesh Mehta

Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia, Minesh Mehta

Radiotherapy Innovations to Optimize Brain Metastases Control, Minesh Mehta

CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA, Minesh Mehta, Rupesh Kotecha, and Yazmin Odia

CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani

HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani

Breast Cancer Surgery, Jane Mendez

Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation, Jane Mendez

A Novel Pre-plan Technique for On-table Adaptation of Pancreatic Stereotactic MR-guided Online Adaptive Radiotherapy, Kathryn Mittauer, Michael Chuong, Jessika Contreras, Diane Alvarez, Tino Romaguera, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez

Emerging Ablative and Transarterial Therapies for Pancreatic Cancer, Govindarajan Narayanan, Antonio Ucar, Ripal Gandhi, Arian Nasiri, Prasuna Inampudi, and Horacio Asbun

DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani

ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani

Biological activity of weekly ONC201 in adult recurrent glioblastoma patients, Yazmin Odia and Minesh Mehta

Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma, Yazmin Odia and Minesh Mehta

Early imaging marker of progressing glioblastoma: a window of opportunity, Yazmin Odia and Minesh Mehta

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma, Yazmin Odia and Minesh Mehta

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study, Claudia Paba Prada

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma, Guilherme Rabinowits

CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma, Guilherme Rabinowits

Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial, Guilherme Rabinowits

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck, Guilherme Rabinowits

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma, Guilherme Rabinowits

RADT-31. PATTERNS OF CARE IN THE USE OF ADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN LOW GRADE GLIOMA PATIENTS IN THE UNITED STATES FROM 2010-2016, Warren Rehrer, Yazmin Odia, Muni Rubens, Noah Kalman, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

The Use of Adjuvant Radiotherapy and Chemotherapy in Low Grade Glioma Patients in the United States from 2010-2016, Warren Rehrer, Muni Rubens, Katherine Von Werne, Yazmin Odia, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

Principles of Radiation Therapy in Breast Cancer, Maria-Amelia Rodrigues

Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016, Muni Rubens, Anshul Saxena, Sankalp Das, Chintan Bhatt, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta

Bioengineered Exosomal Extracellular Vesicles in Cancer Therapeutics, Marco Ruiz Andia

Revisiting Early Palliative Care for Patients With Hematologic Malignancies and Bone Marrow Transplant: Why the Delay?, Marco Ruiz Andia

Survival Impact Of Postoperative Radiotherapy Timing In Pediatric And Young Adult Ependymoma, Sunny Shah, Kevin Gates, Chase Mallory, Muni Rubens, Haley Appel, Noah Kalman, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

Dietary patterns and thyroid cancer risk: a population-based case-control study, Robert Udelsman

Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut, Robert Udelsman

Phytoestrogens and Thyroid Cancer Risk: A Population-Based Case-Control Study in Connecticut, Robert Udelsman

Polybrominated Diphenyl Ethers, Polybrominated Biphenyls, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study, Robert Udelsman

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, Miguel Villalona Calero

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study, Miguel Villalona Calero

Safety of Proton Therapy for Patients With Primary Central Nervous System Germinoma and Non-Germinomatous Germ Cell Tumors: Report from a Multi-Institutional Database Analysis, Katherine Von Werne, Melanie Naranjo, Haley Appel, Warren Rehrer, Muni Rubens, Michael Chuong, Minesh Mehta, Rupesh Kotecha, and Matthew Hall

A Unique Airway Management Method for a Patient with a supraglottic Liposarcoma: A Case Report, Geoffrey Young

Submissions from 2019 2019

Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons, Horacio Asbun

Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases, Horacio Asbun

Mentor of the Month Series: Laparoscopic Training in the United States, Horacio Asbun

Minimally Invasive Approaches to Pancreatic Cancer, Horacio Asbun

National Pancreatic Fistula Rates After Minimally Invasive Pancreaticoduodenectomy Are Improving with Time: A NSQIP Analysis, Horacio Asbun

Metastatic vertebral lesion mimicking an atypical hemangioma with negative 18F-FDG positron emission tomography-computed tomography, Ana Cecilia Belzarena Genovese

Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial (18)F-FDG PET/CT, Michael Chuong

Consensus Report From the Miami Liver Proton Therapy Conference, Michael Chuong and Alonso Gutierrez

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA), Michael Chuong and Minesh Mehta

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?, Michael Chuong and Minesh Mehta

Transoral Endoscopic Thyroidectomy Vestibular Approach, Neeta Erinjeri and Robert Udelsman

Volume-outcome relationship in parathyroid surgery, Neeta Erinjeri and Robert Udelsman

EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host, Matthew Hall, Lyle Feinstein, Sergio Gonzalez-Arias, and Yazmin Odia

First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report, Matthew Hall, Yazmin Odia, Doured Daghistani, and Minesh Mehta

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201, Matthew Hall, Yazmin Odia, and Minesh Mehta

CMET-06. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS, Rupesh Kotecha

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis, Rupesh Kotecha

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha

Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer, Rupesh Kotecha

The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis, Rupesh Kotecha

The Complexity of Managing Large Brain Metastasis, Rupesh Kotecha and Minesh Mehta

Updates in the management of intradural spinal cord tumors: a radiation oncology focus, Rupesh Kotecha and Minesh Mehta

Barriers to Accrual and Enrollment in Brain Tumor Trials, Minesh Mehta

Comparison of Epidemiology and Outcomes in Neuro-Oncology Between the East and the West: Challenges and Opportunities, Minesh Mehta

Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis, Minesh Mehta

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma, Minesh Mehta

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes, Minesh Mehta

Letter: When Less is More: Dexamethasone Dosing for Brain Tumors, Minesh Mehta

Low-Grade Glioma Radiotherapy Treatment and Trials, Minesh Mehta

Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous, Minesh Mehta

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges, Minesh Mehta

NRG brain tumor specialists consensus guidelines for glioblastoma contouring, Minesh Mehta

Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review, Minesh Mehta

Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933, Minesh Mehta

The association between BMI and BSA–temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525, Minesh Mehta

Core curriculum guidelines for a required clinical neurology experience, Yazmin Odia

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations, Yazmin Odia

Incidental MITF, p.E318K Pathogenic Variant in Three Independent Cases Undergoing Hereditary Cancer Risk Assessment, Jessica Ordonez, Jeffrey Boyd, and Arelis Martir-Negron

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma, Guilherme Rabinowits

Everolimus in Anaplastic Thyroid Cancer: A Case Series, Guilherme Rabinowits

Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence, Guilherme Rabinowits

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma, Guilherme Rabinowits

Needle track seeding in renal mass biopsies, Andrew Renshaw, Alex Powell, Jorge Caso, and Edwin Gould

Lack of Efficacy of the Neutropenic Diet in Decreasing Infections among Cancer Patients: A Systematic Review, Muni Rubens, Anshul Saxena, Peter McGranaghan, Emir Veledar, Ana Viamonte Ros, and Rupesh Kotecha

Cell phone use and risk of thyroid cancer: a population-based case-control study in Connecticut, Robert Udelsman